SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001640455-20-000054
Filing Date
2020-06-02
Accepted
2020-06-02 08:13:07
Documents
3
Effectiveness Date
2020-06-02

Document Format Files

Seq Description Document Type Size
1 DEFA14A jnce06022020defa14a.htm DEFA14A 39230
2 jouncelogo.jpg GRAPHIC 66963
3 rmsignature.jpg GRAPHIC 2641
  Complete submission text file 0001640455-20-000054.txt   136302
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37998 | Film No.: 20935620
SIC: 2836 Biological Products, (No Diagnostic Substances)